Erectile dysfunction: A non sufficiently valued problem in internal medicine. Study of patients and related medication;Disfunción eréctil: Un problema poco valorado en medicina interna. Estudio de pacientes y medicación relacionada

Anales de Medicina Interna

Volumn 23, Issue 3, 2006, Pages 115-118

  Villamil Cajoto, Iago ^a,b   Diaz Peromingo J A ^a   Sanchez Leira J ^a   Garcia Suarez F ^a   Saborido Forjan, J ^a   Iglesias Gallego, M ^a  

^a Hospital da Barbanza   (Spain)

^b University Hospital of Santiago de Compostela   (Spain)

Author keywords

Erectile dysfunction; Internal Medicine; Male

Indexed keywords

ALCOHOL; ALDOSTERONE ANTAGONIST; ALPRAZOLAM; ATENOLOL; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CHLORTALIDONE; CLONIDINE; CLOZAPINE; DIAZEPAM; GUANADREL; GUANETHIDINE; HYDRALAZINE; LABETALOL; LEUPRORELIN; LORAZEPAM; MAPROTILINE; METHOTREXATE; METHYLDOPA; METIROSINE; METOPROLOL; NAFARELIN; PINDOLOL; PRAZOSIN; PROPRANOLOL DERIVATIVE; RESERPINE; SPIRONOLACTONE; THIORIDAZINE; TRAZODONE; UNINDEXED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ERECTILE DYSFUNCTION; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INTERNAL MEDICINE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RISK FACTOR; SCORING SYSTEM; SEXUAL BEHAVIOR; TOBACCO; AGE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; ENDOCRINE DISEASE; IMPOTENCE; NEUROLOGIC DISEASE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SMOKING; VASCULAR DISEASE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ENDOCRINE SYSTEM DISEASES; HUMANS; IMPOTENCE; INTERNAL MEDICINE; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING; VASCULAR DISEASES;

EID: 33746791630     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. NIH Consensus Conference. Impotence. NIH Consensus Panel on Impotence JAMA 1993; 270: 83-90.
2. Gro Harlem Brundtland. The Word health report 1999. Disponible en línea http//:ftp.who.int/gb/pdf_files/WHA52/ew4.pdf. (última consulta 31 mayo2005).
3. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirpatrick J, Mishra A. The International Index of Erectile Dysfunction (IIED): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
4. Cappelleri JC, Siegel RL, Glasser DB, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile dysfunction and the sexual health inventory for men. Clin Ther 2001; 10: 1707-1719.
5. Kinsey, AC. Sexual behaviour in the human male. Saunders, Philadelphia, 1948.
6. Feldman, HA, Goldstein, I, Hatzichristou, DJ, et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts male ageing study. J Urol 1994; 151: 54.
7. Martín Morales A, Sánchez Cruz JJ, Sáenz de Tejada I, Rodríguez Vela L, Jiménez Cruz JF, Burgos-Rodríguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiología de la Disfunción Eréctil Masculina Study. J Urol 2001; 166: 53-58.
8. De Busck R, Dorry Y, Goldstein I, jackson G, Kaul S, Kimmel SE et al. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. Am J Cardiol 2000; 86: 175-181.
9. Drugs that cause sexual dysfunction: an update. The Medical Letter 1992; 34:73-8.
10. Morgentaler A. Male Impotence. Lancet 1999; 354: 1713-1718.
11. Vilke GM, Harrigan RA, Ufberg JW, Chan TC. Emergency evaluation and treatment of priapism. J Emerg Med 2004; 26: 325-9.